Exocrine pancreatic insufficiency: accuracy and clinical value of the uniformly labelled 13C-Hiolein breath test.

B Lembcke, B Braden, W F Caspary

Medical Department II, Centre of Internal Medicine, University Hospital, JW Goethe-University Frankfurt, Germany.

BACKGROUND AND AIMS: The 13C-Hiolein breath test (98% [U-13C] labelled long chain triglyceride mixture (highly labelled triolein) was evaluated as a non-invasive, non-radioactive test for exocrine pancreatic insufficiency. Accuracy and clinical validity were examined with reference to both the secretin pancreozymin test and faecal fat analysis. METHODS: A secretin pancreozymin test and faecal fat analysis were performed in 46 patients, 30 with exocrine pancreatic insufficiency and 16 with normal pancreatic function. In all of these patients and in seven healthy volunteers (controls), a 13C-Hiolein breath test was performed using 2 mg/kg [U-13C] labelled Hiolein with a standard risk snack (1.5 g/kg; 25% fat). 13CO2/12CO2 enrichment in the exhaled breath was measured by isotope ratio mass spectrometry. RESULTS: In patients with pancreatic steatorrhoea the 13CO2 response was below the 95% confidence interval of 13CO2 exhalation in the controls. These responses were also diminished (p < 0.001) compared with patients with impaired lipase output but normal fat excretion and with disease as well as healthy controls. There was a linear correlation between stimulated lipase output and the ratio of lipase output/13CO2 response (r = 0.95). Among the 40 patients in whom direct pancreatic function testing was clinically indicated, the sensitivity of the 13C-Hiolein test for detecting steatorrhoea was 91.7%, with a specificity of 85.7%. CONCLUSIONS: In patients with pancreatic disease the 13C-Hiolein breath test reflects impaired lipase output and indicates decompensated lipolysis. The 13C-Hiolein breath test is a convenient alternative to faecal fat analysis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Thomas, P D, Forbes, A, Green, J, Howdle, P, Long, R, Playford, R, Sheridan, M, Stevens, R, Valori, R, Walters, J, Addison, G M, Hill, P, Brydon, G (2003). Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut 52: v1-15 [Full Text]  
• Heverhagen, J. T., Müller, D., Battmann, A., Ishaque, N., Boehm, D., Katschinski, M., Wagner, H.-J., Klose, K. J. (2001). MR Hydrometry to Assess Exocrine Function of the Pancreas: Initial Results of Noninvasive Quantification of Secretion. Radiology 218: 61-67 [Abstract] [Full Text]  
• Kalivianakis, M., Minich, D. M, Havinga, R., Kuipers, F., Stellaard, F., Vonk, R. J, Verkade, H. J (2000). Detection of impaired intestinal absorption of long-chain fatty acids: validation studies of a novel test in a rat model of fat malabsorption. Am. J. Clin. Nutr. 72: 174-180 [Abstract] [Full Text]  
• Evenepoel, P, Hiele, M, Geypens, B, Geboes, K P, Rutgeerts, P, Ghoos, Y (2000). 13C-egg white breath test: a non-invasive test of pancreatic trypsin activity in the small intestine. Gut 46: 52-57 [Abstract] [Full Text]  
• MURPHY, G M (1998). Depressing acid, deconjugating bile. Gut 42: 154-155 [Full Text]  
• Ventrucci, M, Cipolla, A, Ubalducci, G M, Roda, A, Roda, E (1998). 13C labelled cholesteryl octanoate breath test for assessing pancreatic exocrine insufficiency. Gut 42: 81-87 [Abstract] [Full Text]